{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:08:31Z","timestamp":1788318511828,"version":"build-2803163510"},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,4,15]]},"DOI":"10.2169\/internalmedicine.5917-20","type":"journal-article","created":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T22:05:37Z","timestamp":1606082737000},"page":"1287-1291","source":"Crossref","is-referenced-by-count":3,"title":["The Effect of Intravenous Methylprednisolone on Recurrent Exacerbation in Hematologic Malignancy-associated Progressive Multifocal Leukoencephalopathy"],"prefix":"10.2169","volume":"60","author":[{"given":"Ryutaro","family":"Nakamura","sequence":"first","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Tsukamoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isamu","family":"Yamakawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoh","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Kawai","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Sanada","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Urushitani","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shiga University of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mizusawa H, Kishida S, Saijo M, et al. [Progressive multifocal leukoencephalopathy (PML)]. Rinsho Shinkeigaku (Clin Neurol) 51: 1051-1057, 2011 (in Japanese, Abstract in English).","DOI":"10.5692\/clinicalneurol.51.1051"},{"key":"2","unstructured":"2. Wattjes MP, Wijburg MT, van Eijk J, et al. Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS. J Neurol Neurosurg Psychiatry 89: 535-541, 2018."},{"key":"3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1212\/WNL.52.3.623","volume":"52","author":"DB Clifford","year":"1999","unstructured":"3. Clifford DB, Yiannoutsos C, Glicksman M, et al. HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 52: 623-625, 1999.","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"4","unstructured":"4. Clifford DB, De Luca A, DeLuca A, et al. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 9: 438-446, 2010."},{"key":"5","unstructured":"5. Neil EC, DeAngelis LM. Progressive multifocal leukoencephalopathy and hematologic malignancies: a single cancer center retrospective review. Blood Adv 1: 2041-2045, 2017."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mateen FJ, Muralidharan R, Carone M, et al. Progressive multifocal leukoencephalopathy in transplant recipients. Ann Neurol 70: 305-322, 2011.","DOI":"10.1002\/ana.22408"},{"key":"7","unstructured":"7. Sahraian MA, Radue EW, Eshaghi A, Besliu S, Minagar A. Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis. Eur J Neurol 19: 1060-1069, 2012."},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Tan K, Roda R, Ostrow L, McArthur J, Nath A. PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology 72: 1458-1464, 2009.","DOI":"10.1212\/01.wnl.0000343510.08643.74"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tan IL, McArthur JC, Clifford DB, Major EO, Nath A. Immune reconstitution inflammatory syndrome in natalizumab-associated PML. Neurology 77: 1061-1067, 2011.","DOI":"10.1212\/WNL.0b013e31822e55e7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sanjo N, Kina S, Shishido-Hara Y, et al. Progressive multifocal leukoencephalopathy with balanced CD4\/CD8 T-cell infiltration and good response to mefloquine treatment. Intern Med 55: 1631-1635, 2016.","DOI":"10.2169\/internalmedicine.55.6051"},{"key":"11","unstructured":"11. Shelburne SA, Montes M, Hamill RJ. Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother 57: 167-170, 2006."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Gheuens S, Smith DR, Wang X, Alsop DC, Lenkinski RE, Koralnik IJ. Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS. Neurology 78: 1390-1393, 2012.","DOI":"10.1212\/WNL.0b013e318253d61e"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Vermersch P, Kappos L, Gold R, et al. Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy. Neurology 76: 1697-1704, 2011.","DOI":"10.1212\/WNL.0b013e31821a446b"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Antoniol C, Jilek S, Schluep M, et al. Impairment of JCV-specific T-cell response by corticotherapy: effect on PML-IRIS management? Neurology 79: 2258-2264, 2012.","DOI":"10.1212\/WNL.0b013e3182768983"},{"key":"15","unstructured":"15. Yuan C, Deberardinis C, Patel R, et al. Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation: Case report and review of the literature. Transpl Infect Dis 20: e12879, 2018."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tan CS, Broge TA, Ngo L, et al. Immune reconstitution after allogeneic hematopoietic stem cell transplantation is associated with selective control of JC virus reactivation. Biol Blood Marrow Transplant 20: 992-999, 2014.","DOI":"10.1016\/j.bbmt.2014.03.018"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/8\/60_5917-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T04:01:12Z","timestamp":1618632072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/8\/60_5917-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5917-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,15]]}}}